Litcius/Paper detail

Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer

Jessica A. Hellyer, Maya N. White, Rebecca M. Gardner, Kristen Cunanan, Sukhmani K. Padda, Millie Das, Kavitha Ramchandran, Joel W. Neal, Heather A. Wakelee

2021Clinical Lung Cancer27 citationsDOI

Topics & Concepts

MedicineT790MLung cancerExonCDKN2AOncologyCancer researchEpidermal growth factor receptorInternal medicineMutationOsimertinibCancerGeneGefitinibErlotinibBiologyGeneticsLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer | Litcius